Ovensa Inc.

📍 Canada🗓 Founded 2012👥 3 employees💰 Last funded Oct 2020
Biotechnology Research🌐 ovensa.com
Website LinkedIn
Ovensa is a Canadian preclinical stage company committed to advance its siRNA lead candidate silencing galectin-1 overexpression in the tumor microenvironment to improve therapeutic outcomes of an immuno-oncology anti-PD-1 checkpoint inhibitor as a combination therapy in head & neck cancer. The company is also advancing its collaboration programs with pharmaceutical companies to develop precision and combination medicines through its proprietary TRIOZAN™ Platform for specific indications.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in Ovensa Inc.?
Ovensa Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Ovensa Inc. last raise funding?
The most recent investment in Ovensa Inc. recorded on gritt.io was in October 2020.
When was Ovensa Inc. founded?
Ovensa Inc. was founded in 2012.
What industry is Ovensa Inc. in?
Ovensa Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ovensa Inc. based?
Ovensa Inc. is headquartered in Canada.